Loading clinical trials...
Loading clinical trials...
The subjects that meet the inclusion and exclusion criteria and consent to participate in protocol 22001 will be offered participation in 22001A which will evaluate secreted protein before and after t...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Seaside Therapeutics, Inc.
NCT07209462 · Fragile X Syndrome
NCT06560242 · Fragile X Syndrome
NCT00768820 · Velocardiofacial Syndrome, Williams Syndrome, and more
NCT06139172 · Telomeric 22Q13 Monosomy Syndrome, Tuberous Sclerosis, and more
NCT06677866 · Fragile X Syndrome (FXS), Autism Spectrum Disorder
Southwest Autism Research & Resource Center
Phoenix, Arizona
University of California-Los Angeles Neuropsychiatric Institute
Los Angeles, California
M.I.N.D. Institute
Sacramento, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions